🇺🇸 Linezolid dose personalization based on TDM in United States

Linezolid dose personalization based on TDM (Linezolid dose personalization based on TDM) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Linezolid dose personalization based on TDM in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Linezolid dose personalization based on TDM approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Linezolid dose personalization based on TDM in United States?

Marco Schiuma is the originator. The local marketing authorisation holder may differ — check the official source linked above.